南昌(chang)2019年(nian)10月(yue)24日(ri) /美通社/ --10月(yue)10日(ri)，“2019中(zhong)(zhong)國(guo)(guo)(guo)化(hua)(hua)學制藥(yao)(yao)(yao)(yao)行(xing)(xing)業(ye)(ye)(ye)(ye)(ye)年(nian)度峰會(hui)”在南昌(chang)舉(ju)辦。會(hui)議發布了由中(zhong)(zhong)國(guo)(guo)(guo)化(hua)(hua)學制藥(yao)(yao)(yao)(yao)工(gong)業(ye)(ye)(ye)(ye)(ye)協(xie)會(hui)、中(zhong)(zhong)國(guo)(guo)(guo)醫藥(yao)(yao)(yao)(yao)商業(ye)(ye)(ye)(ye)(ye)協(xie)會(hui)、中(zhong)(zhong)國(guo)(guo)(guo)非處方藥(yao)(yao)(yao)(yao)物協(xie)會(hui)、中(zhong)(zhong)國(guo)(guo)(guo)醫藥(yao)(yao)(yao)(yao)企(qi)業(ye)(ye)(ye)(ye)(ye)發展促進會(hui)共同組織(zhi)推薦的(de)“2019中(zhong)(zhong)國(guo)(guo)(guo)化(hua)(hua)學制藥(yao)(yao)(yao)(yao)行(xing)(xing)業(ye)(ye)(ye)(ye)(ye)優(you)秀(xiu)(xiu)企(qi)業(ye)(ye)(ye)(ye)(ye)和(he)優(you)秀(xiu)(xiu)產(chan)(chan)(chan)品(pin)(pin)品(pin)(pin)牌(pai)榜”。衛材(cai)（中(zhong)(zhong)國(guo)(guo)(guo)）藥(yao)(yao)(yao)(yao)業(ye)(ye)(ye)(ye)(ye)有限公司（以下(xia)簡稱“衛材(cai)中(zhong)(zhong)國(guo)(guo)(guo)藥(yao)(yao)(yao)(yao)業(ye)(ye)(ye)(ye)(ye)”）共獲得“2019中(zhong)(zhong)化(hua)(hua)學制藥(yao)(yao)(yao)(yao)行(xing)(xing)業(ye)(ye)(ye)(ye)(ye)工(gong)業(ye)(ye)(ye)(ye)(ye)企(qi)業(ye)(ye)(ye)(ye)(ye)綜(zong)合實力百(bai)強(qiang)（第(di)50位）、 2019中(zhong)(zhong)國(guo)(guo)(guo)化(hua)(hua)學制藥(yao)(yao)(yao)(yao)行(xing)(xing)業(ye)(ye)(ye)(ye)(ye)原研(yan)藥(yao)(yao)(yao)(yao)、專(zhuan)利(li)藥(yao)(yao)(yao)(yao)優(you)秀(xiu)(xiu)產(chan)(chan)(chan)品(pin)(pin)品(pin)(pin)牌(pai)（安理申）、2019中(zhong)(zhong)國(guo)(guo)(guo)化(hua)(hua)學制藥(yao)(yao)(yao)(yao)行(xing)(xing)業(ye)(ye)(ye)(ye)(ye)消化(hua)(hua)系統類優(you)秀(xiu)(xiu)產(chan)(chan)(chan)品(pin)(pin)品(pin)(pin)牌(pai)（波利(li)特）、2019中(zhong)(zhong)國(guo)(guo)(guo)化(hua)(hua)學制藥(yao)(yao)(yao)(yao)行(xing)(xing)業(ye)(ye)(ye)(ye)(ye)神經、精神系統類優(you)秀(xiu)(xiu)產(chan)(chan)(chan)品(pin)(pin)品(pin)(pin)牌(pai)（彌可保、安理申、敏使朗）”六項殊榮。

中國化(hua)學制藥(yao)行業(ye)(ye)年度峰會自2011年至今(jin)已連(lian)續舉(ju)辦9屆(jie)，本(ben)屆(jie)峰會圍繞(rao)“質量·誠(cheng)信·品牌”舉(ju)辦主題論壇，內(nei)容(rong)涉及醫(yi)藥(yao)工(gong)(gong)(gong)業(ye)(ye)經濟運(yun)行與(yu)產業(ye)(ye)發展(zhan)情(qing)況、新修訂《藥(yao)品管理法》政策解讀和藥(yao)品臨床評價介紹等(deng)內(nei)容(rong)。峰會還舉(ju)辦了(le)由中國化(hua)學制藥(yao)工(gong)(gong)(gong)業(ye)(ye)協(xie)會組織編纂的《2019制藥(yao)工(gong)(gong)(gong)業(ye)(ye)藍皮書》發布(bu)儀式。

中國醫藥產業的飛速發展得到了世界的矚目，就衛材的全球業務構成看，中國已成為衛材現在以及未來的重要市場。衛材已在中國開啟 “E-WAY 2025（衛材之路）”計劃，圍繞“關愛、創新、準入、自治”四個關鍵詞展開，希望衛材將會成為令人尊敬的hhc（human health care）“關心人類健康(kang)”的(de)(de)制藥(yao)企(qi)業(ye)。目(mu)前，衛(wei)材(cai)中國藥(yao)業(ye)已形成以神(shen)經科學領域、腫瘤（特藥(yao)）領域、消化肝病(bing)領域為重點領域，多達數十(shi)種藥(yao)品在中國銷售(shou)的(de)(de)發展(zhan)規模。對于(yu)未來(lai)在中國市場的(de)(de)發展(zhan)，衛(wei)材(cai)中國藥(yao)業(ye)希望為中國的(de)(de)患(huan)者帶來(lai)更多福音并與社會各(ge)界共同在疾(ji)病(bing)認知、預防(fang)與控制、患(huan)者關愛等多方面做出(chu)貢(gong)獻。